scholarly journals B-PO01-024 MECHANICAL AV SYNCHRONY PROVIDED BY A LEADLESS PACEMAKER SUCCESSFULLY TIMES VENTRICULAR ACTIVATION TO THE COMPLETION OF ATRIAL CONTRACTION

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S60
Author(s):  
Alan Cheng ◽  
Larry A. Chinitz ◽  
Surinder Kaur Khelae ◽  
Clemens Steinwender ◽  
Todd J. Sheldon ◽  
...  
2021 ◽  
Vol 14 (6) ◽  
pp. e243365
Author(s):  
Amar Mistry ◽  
Shital Assuvinkumar ◽  
Gasem Gador ◽  
Riyaz Somani

We report the first leadless pacemaker (L-PM) providing atrioventricular synchronous pacing implanted into a heart transplant patient receiving chronic immunosuppressive therapy. The patient presented with syncope corresponding to sinus rhythm with high-grade atrioventricular block. Previously, L-PMs provided only single-chamber ventricular sensing and pacing. A Micra AV lL-PM provides atrioventricular synchronous pacing by tracking mechanical atrial contraction. L-PMs, which now support broader indications, should be considered in patients at greater risk of infection.


EP Europace ◽  
2018 ◽  
Vol 20 (suppl_1) ◽  
pp. i1-i1
Author(s):  
C Steinwender ◽  
L Mont ◽  
G Z Duray ◽  
N Clementy ◽  
L Chinitz ◽  
...  

Author(s):  
Christophe Garweg ◽  
Surinder Kaur Khelae ◽  
Joseph Yat Sun Chan ◽  
Larry Chinitz ◽  
Philippe Ritter ◽  
...  

2021 ◽  
Vol 4 (57) ◽  
pp. 4-7
Author(s):  
Przemysław Mitkowski

In December 2013 leadless pacing system was implanted in humans for the first time. Both in IDE and PAR re­gistries high effectiveness and safety were confirmed. In the mentioned registries risk of severe complication was reduced by 48 and 63% respectively. The reduced risk was mainly shown in a decreased percentage of hospitali­zations and system revisions. MICRA VR system has activity detectors placed in three planes, which allows to detect onset and end of ventricular contraction as well as early, and atrial contraction related ventricular filling. This property allowed to design an algorithm to detect mechanical atrial contraction. This algorithm caused an increase in atrioventricular synchrony to 80,0 and 94,4% in patients with advanced AV block and preserved conduction, respectively. In patients with advanced AV block percentage of those who reached more than 70% of atrioventricular synchrony was 95%. Parameters which increase the likelihood of high percentage of AV synchrony are standard deviation of consecutive P-P intervals < 5/min. and lower E/A in echocardiography. Practical implementation of a new algorithm required redesigning of a circuit to reduce power consumption. New system MICRA AV was developed, which volume, mass and longevity are comparable with MICRA VR.


Author(s):  
Gurukripa Kowlgi ◽  
Andrew Tseng ◽  
Nathan Tempel ◽  
Mark Henrich ◽  
Kalpathi Venkatachalam ◽  
...  

Aims: The MicraTM transcatheter pacing system (TPS) (Medtronic) is the only leadless pacemaker that promotes atrioventricular (AV) synchrony via accelerometer-based atrial sensing. Data regarding the real-world experience with this novel system are currently lacking. We sought to characterize patients undergoing MicraTM -AV implants, describe percentage AV synchrony achieved, and analyze the causes for suboptimal AV synchrony. Methods: In this retrospective cohort study, electronic medical records from 56 consecutive patients undergoing MicraTM -AV implants at the Mayo Clinic sites in Minnesota, Florida, and Arizona with a minimum follow-up of 3 months were reviewed. Demographic data, comorbidities, echocardiographic data, and clinical outcomes were compared among patients with and without atrial synchronous-ventricular pacing (AsVP) ≥70%. Results: Fifty-six percent of patients achieved AsVP ≥70%. Patients with adequate AsVP had smaller body mass indices, a lower proportion of congestive heart failure and pulmonary hypertension. Echocardiographic parameters and procedural characteristics were similar across the two groups. Active device troubleshooting was associated with higher AsVP. The likely reasons for low AsVP were persistent atrial arrhythmias, small A4-wave amplitude, and inadequate device reprogramming. Importantly, in patients with low AsVP, subjective clinical worsening was not noted during follow-up. Conclusion: With the increasing popularity of leadless PM, it is paramount for device implanting teams to be familiar with common predictors of AV synchrony and troubleshooting with MicraTM -AV devices.


2019 ◽  
pp. 199-206
Author(s):  
О. З. Скакун ◽  
С. В. Федоров ◽  
О. С. Вербовська ◽  
І. З. Твердохліб

Distinctive atrioventricular type I heart block is diagnosed when the PQ interval is 0.30 s. or more. Prolongation of the PQ interval more than 0.50 s. is a very rare condition. Usually it is associated with a pseudo-pacemaker syndrome. The last one manifests itself with dizziness, syncope, general weakness, shortness of breath upon physical exertion, cough, seizures, cold sweat, a feeling of pulsation in the head, neck and abdomen, a headache, paroxysmal nocturnal dyspnea, swelling of the lower extremities, tachypnea and jugular venous pulsation. The P wave appears immediately after the previous QRS complex. Atrial contraction occurs at the moment when the ventricles don’t relax after the previous contraction; due to the fact that pressure in the ventricles at this moment is higher than in the atria, the tricuspid and mitral valves remains closed. During the atrial contraction, most of the blood is ejected not into the ventricles, but backward into the pulmonary veins from the left atrium and into the venae cavae from the right atrium. Also, an atrial kick is absent which results in a less ventricular filling. There is increased pressure in the atria leading to their distension and excessive secretion of the atrial natriuretic peptide. A case report of the distinctive atrioventricular type I heart block associated with the pseudo-pacemaker syndrome is described. The patient suffered from a pre-syncope, short-term dizziness during the previous two days, tinnitus, general weakness, feeling of pulsation in the abdomen, neck, head, which interfered with his sleep. He developed these complaints after an infectious disease, which manifested as a runny nose and sore throat. In this patient, an extremely prolonged PQ interval up to 0.70 s. was observed. Also, episodes of Mobitz I and Mobitz type II atrioventricular block were detected. During the monitoring of patient state, the interval PQ was gradually shortening, and in 1 month it reached the normаl duration. It can be assumed that in the case of distinctive atrioventricular type I heart block, a significant prolongation of the refractory period in the rapid pathways of the AV-node plays a key role in the pathogenesis of this condition. According to the recommendations of the ACC/AHA (1998), for patients with distinctive atrioventricular type I heart block accompanied by the pseudo-pacemaker syndrome and documented alleviation of symptoms with temporary AV pacing, the pacemaker implantation should be considered (IIaB). The implantation of dual chamber pacemaker may reduce symptoms and lead to an improvement in the functional state of patients, in whom shortening of the interval between atrial and ventricular contractions improves hemodynamics. For asymptomatic patients with the PQ interval of ≥ 0.30 s, pacemaker is not recommended. The distinctive atrioventricular type I heart block in patients with pseudo-pacemaker syndrome is a rare condition and often remains undiagnosed. But it may have a benign course with a gradual normalization of the PQ interval. Indications for permanent pacemaker implantation should be reviewed as this block may be completely reversible. A permanent pacemaker may be used in the case of absence of positive dynamics in a shortening of the PQ interval.    


Sign in / Sign up

Export Citation Format

Share Document